What is Bolt Biotherapeutics, Inc. (BOLT)?
Bolt Biotherapeutics, Inc. is a biotechnology company specializing in the development of immuno-oncology therapies. The company focuses on creating novel treatments that harness the immune system to target and destroy cancer cells. Its approach involves the design of Probody therapeutics, which are antibody prodrugs engineered to be activated in the tumor microenvironment, potentially reducing systemic toxicity. Bolt Biotherapeutics engages in research and development activities aimed at advancing its pipeline of candidates through preclinical and clinical stages. The company collaborates with academic institutions and industry partners to support its scientific and clinical programs. Its work contributes to the broader field of cancer immunotherapy by exploring innovative mechanisms to improve treatment specificity and efficacy. Bolt Biotherapeutics operates within the regulatory environment governing pharmaceutical development and clinical trials.
Bolt Biotherapeutics, Inc. Stock Price Today: Live Overview
The price today is shaped by market activity, with Bolt Biotherapeutics, Inc. at $4.7704. Intraday price has varied from $4.4896 to $4.6796, showing a daily percentage change of -0.2208%.
FAQ: Bolt Biotherapeutics, Inc. (BOLT)
What is the current price of BOLT stock?
Bolt Biotherapeutics, Inc. is trading at $4.7704.
Does BOLT pay dividends?
Bolt Biotherapeutics, Inc. does not pay dividends.
Does BOLT have a formal corporate presence or regional headquarters in the UAE?
Bolt Biotherapeutics, Inc. operates in the UAE exclusively through partners and distributors.
What is BOLT best known for?
The company is most famous for developing immuno-oncology therapies.
What assets are typically shown together with BOLT?
Commonly shown alongside BOLT: Loar Holdings Inc, Invivyd Inc., Lesaka Technologies Inc
Latest shares articles



